Table 3. Multivariate analysis to identify factors predicting poor overall survival and disease-free survival of patients with hepatocellular carcinoma after curative hepatectomy.^* .

	Hazard Ratio	95% CI	P
Overall Survival
Diabetes mellitus	1.482	1.044–2.104	0.028
AFP (≥400 ng/mL)	1.603	1.108–2.319	0.012
Albumin (<35 g/L)	1.634	1.035–2.577	0.035
GGT (≥50 U/L)	1.891	1.245–2.872	0.003
Tumor capsule (Incomplete)	1.553	1.073–2.247	0.020
Macrovascular invasion	2.333	1.561–3.486	<0.001
Tumor size (≥10 cm)	1.112	1.012–1.223	0.027
Tumor number (≥3)	2.431	1.596–3.702	<0.001
Differentiation degree (Poorly)	2.380	1.266–4.475	<0.001
Disease-free survival
Diabetes mellitus	0.878	0.624–1.237	0.458
AFP ( ≥400 ng/mL)	1.399	1.011–1.937	0.043
Albumin (<35 g/L)	1.425	0.944–2.151	0.092
GGT (≥50 U/L)	1.450	1.040–2.020	0.028
Tumor capsule (Incomplete)	1.563	1.136–2.146	0.006
Macrovascular invasion	1.638	1.124–2.388	0.010
Tumor size (≥10 cm)	1.098	1.000–1.205	0.049
Tumor number (≥3)	2.138	1.453–3.147	<0.001
Differentiation degree (Poorly)	1.814	1.102–2.984	0.019

*Calculated using data from all patients in the original cohort (without propensity score matching).

Abbreviations: AFP, alpha-fetoprotein; CI, confidence interval, GGT, γ-glutamyl transferase.